Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q3 2025 · 10-Q
Revenue$2.86K$2.86K−56.6% vs Q3 2024 Net Income-$1.71M-$1.71MN/M vs Q3 2024 EPS Diluted-$0.98-$0.98N/M vs Q3 2024 Operating Income-$1,711,597N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,556,252N/M Margins · derivedOperating margin-59950.9%−38538.0 pt vs Q3 2024
Net margin-60053.8%−38586.2 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end